Answers are grounded in this paper and cite their sources.
Investigates the influence of an additional pregnancy on diabetes risk factors in parous women, suggesting implications for long-term health management.
OBJECTIVE It has been postulated that pregnancies may contribute to the lifetime risk of type 2 diabetes mellitus (T2DM) in women, although direct evidence is lacking. In this context, we hypothesized that pregnancy may impact the long-term natural history of the pathophysiologic determinants of T2DM: insulin sensitivity and β-cell function. We sought to evaluate 10-year trajectories of these features in parous women with and without an additional pregnancy. RESEARCH DESIGN AND METHODS Metabolic characterization was done in 303 women at 1 year postpartum and on three or more occasions over the decade thereafter. Each assessment included an oral glucose tolerance test, enabling serial evaluation of insulin sensitivity/resistance (Matsuda index; HOMA-insulin resistance [IR]), β-cell function (Insulin Secretion-Sensitivity Index-2; insulinogenic index/HOMA-IR), and glycemia. Linear mixed-effect models adjusted for diabetes risk factors were constructed to evaluate the natural time trend of these measures over 10 years in those with (n = 78) and without (n = 225) an additional pregnancy. RESULTS At baseline, women who subsequently had an additional pregnancy were younger (P < 0.001) and more likely to be primiparous (P < 0.001) than their peers. Notably, they had higher covariate-adjusted insulin sensitivity (Matsuda index) at baseline (estimated adjusted average difference 1.64; 95% CI 0.22–2.86) and at 1.5 years’ follow-up (1.28; −0.15 to 2.50), but this difference disappeared by 3.5 years and 5.5 years. The 10-year trajectory of the Matsuda index differed between the groups (time-group interaction P = 0.02), with no differences in trajectories of β-cell function and glycemia. CONCLUSIONS Pregnancy is associated with worsening of the long-term trajectory of insulin sensitivity, revealing both a pathophysiologic basis for enhanced diabetes risk and a target for risk modification.
No takes yet. Share an insight, caveat, or question.
Retnakaran et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: